ATARA
ATARA is a consulting company that provides system development and operational advertising related consulting utilizing Web API. It also provides various services such as business is based on operation-based advertisement consulting, operation-based advertisement report creation support system, and attribution analysis consulting with a focus on listing advertisements. The company specializes in the development and sales of data type automatic creation system “glu" of operation type advertisem... ent report, dashboard construction, and data collection. ATARA offers services and solutions including case list, accompanying in-house support/advertising management training, ad report automation, operational advertising optimization, attribution analysis, marketing system development, LP analysis & improvement, and google analytics & adobe analytics configuration support/implementation consulting. ATARA was founded on September 10, 2009, and is based in Yokohama, Kanagawa, Japan.
ATARA
Industry:
Advertising Consulting Marketing Web Apps
Founded:
2009-09-10
Status:
Active
Email Addresses:
[email protected]
Technology used in webpage:
Domain Not Resolving Apple Mobile Web Clips Icon LetsEncrypt Amazon HSTS ReCAPTCHA Person Schema Google Google Cloud Facebook Sharer
Similar Organizations
Alchemist
Alchemist is a marketing company that provides all kinds of advertising, events and digital marketing services.
Ecrest
E-crest is a web consulting company that conducts web design, web system and application development, and internet advertising operations.
Itago
Itago is an IT company that provides customer services, digital communication, marketing, web tool development and consulting solutions.
Current Employees Featured
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2019-02-26 | All’s & Company | ATARA investment in Corporate Round - All’s & Company | N/A |
More informations about "ATARA"
Allogeneic T-cell Immunotherapy Company - Atara Biotherapeutics
Sep 3, 2024 Atara is an allogeneic T-cell immunotherapy company. We're harnessing the natural biology of T cells—our body’s most effective weapon in fighting disease—to develop …See details»
T-Cell Immunotherapy Technology Platform - Atara Biotherapeutics
Atara's mission is to unleash the extraordinary power of the body's immune system. By harnessing the compelling biological features of T cells—the immune system's most effective …See details»
Responsibility - Atara Biotherapeutics
However, as a clinical stage biotechnology company pushing the boundaries of science, we recognize there is always more that can be done. We actively seek ways to ensure diversity, inclusion, and equitable representation is embraced …See details»
Atara Biotherapeutics to Present Recent Progress and Key …
Jan 8, 2024 Atara is harnessing the natural power of the immune system to develop off-the-shelf cell therapies for difficult-to-treat cancers and autoimmune conditions that can be rapidly …See details»
Atara Biotherapeutics (ATRA)
Nov 12, 2024 Atara is harnessing the natural power of the immune system to develop off-the-shelf cell therapies for difficult-to-treat cancers and autoimmune conditions that can be rapidly delivered to patients from inventory. With cutting …See details»
Atara Biotherapeutics - Crunchbase Company Profile
Atara Biotherapeutics, Inc. (@Atarabio) is an off-the-shelf, allogeneic T-cell immunotherapy company developing novel treatments for patients with cancer, autoimmune, and viral diseases. Atara’s technology platform leverages …See details»
Atara Biotherapeutics - LinkedIn
Atara Biotherapeutics Inc., is a leading allogeneic T-cell immunotherapy company pioneering the development of transformative off-the-shelf therapies for patients with serious diseases including ...See details»
Atara Biotherapeutics Enters Strategic Manufacturing Partnership …
Jan 26, 2022 Following completion of the transaction, FDB, a leading contract development and manufacturing organization (CDMO) in advanced therapies, will provide Atara with access to …See details»
Atara Biotherapeutics Receives FDA Clearance of IND Application …
THOUSAND OAKS, Calif., February 29, 2024--Atara Biotherapeutics, Inc. (Nasdaq: ATRA), a leader in T-cell immunotherapy, leveraging its novel allogeneic Epstein-Barr virus (EBV) T-cell …See details»
Atara Biotherapeutics to Participate in the Goldman Sachs 45th …
THOUSAND OAKS, Calif., June 05, 2024--Atara Biotherapeutics, Inc. (Nasdaq: ATRA), a leader in T-cell immunotherapy, leveraging its novel allogeneic Epstein-Barr virus (EBV) T-cell …See details»
Technology - Atara Biotherapeutics
Atara collects immune cells from healthy donors and then activates, clonally expands, and enriches for T cells with a narrow TCR repertoire and known EBV TCR specificity by using our …See details»
Fujifilm Completes Acquisition of a Dedicated Cell Therapy ...
Apr 4, 2022 TOKYO - FUJIFILM Corporation (President and CEO, Representative Director: Teiichi Goto) today announced that it has completed the acquisition of a dedicated cell therapy …See details»
Atara Biotherapeutics Enters Strategic Manufacturing Partnership …
Jan 26, 2022 Following completion of the transaction, FDB, a leading contract development and manufacturing organization (CDMO) in advanced therapies, will provide Atara with access to …See details»
Bayer and Atara Biotherapeutics Enter Strategic Collaboration for ...
Dec 7, 2020 The role of Bayer’s C> Platform is to steer strategically, ensuring the different parts of the organization complement each other and combining the best in Biotech and …See details»
Developing Novel T-Cell Immunotherapy Treatments - Atara …
Atara Biotherapeutics is a leading off-the-shelf T-cell immunotherapy company developing novel treatments for patients with cancer, autoimmune and viral diseases. Our commitment is to …See details»
Our Herstory - Supporting women and children affected by violence
Our Name. Inspired by The Dinner Party, an important icon of 1970s feminist art which was on tour across Canada at the time, they chose the name Atira. The Dinner Party is a massive …See details»
Atara Biotherapeutics to Present Phase 1 Study Update of ATA188 …
Sep 29, 2021 Atara is applying this one platform to create a robust pipeline including: tab-cel ® in Phase 3 development for Epstein-Barr virus-driven post-transplant lymphoproliferative …See details»
Career Areas - Atara Biotherapeutics
Atara is committed to partnering with graduate and undergraduate programs to find the most promising talent. We begin recruiting in the fall for internship programs that take place the …See details»
Atara Biotherapeutics Announces Second Quarter 2022 Financial …
Aug 8, 2022 Atara announced plans to focus its activities as a leaner organization centered on R&D to further advance the Company’s innovative pipeline, while reducing cash burn Staff will …See details»